ACERAGEN INC (ACGN)

Aceragen Announces Recommendation of Data Monitoring Committee in Terra Study

DURHAM, N.C. and EXTON, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (Nasdaq: ACGN) a clinical-stage biopharmaceutical company...